Concepedia

Amanda E. I. Proudfoot

AE

Statistics

Publications

175

Citations

21.2K

H-Index

78

Active since

1984

Affiliations

Merck Serono S.A. (Switzerland)(Current)

Ono Pharmaceutical (United States)

Ludwig-Maximilians-Universität München

Universidade Federal de Minas Gerais

Amanda E. I. Proudfoot is an author at Merck Serono S.A. (Switzerland) specializing in life sciences, immunology, and inflammation.

Publications per year

1984–2019

175

Publications

175

Glycosaminoglycan binding and oligomerization are essential for the <i>in vivo</i> activity of certain chemokines

Amanda E. I. Proudfoot, Tracy M. Handel, Zoë Johnson et al. · Proceedings of the National Academy of Sciences · 2003 · 768 citations

, , +17

HMGB1 promotes recruitment of inflammatory cells to damaged tissues by forming a complex with CXCL12 and signaling via CXCR4

Milena Schiraldi, Angela Raucci, Laura Martínez‐Muñoz et al. · The Journal of Experimental Medicine · 2012 · 668 citations · Full text

, , +17

Combined Inhibition of CCL2, CX3CR1, and CCR5 Abrogates Ly6C <sup>hi</sup> and Ly6C <sup>lo</sup> Monocytosis and Almost Abolishes Atherosclerosis in Hypercholesterolemic Mice

Christophe Combadière, Stéphane Potteaux, Mathieu P. Rodero et al. · Circulation · 2008 · 647 citations

, , +17

Potent Inhibition of HIV-1 Infectivity in Macrophages and Lymphocytes by a Novel CCR5 Antagonist

Graham Simmons, Paul R. Clapham, Laurent Picard et al. · Science · 1997 · 614 citations

, , +17

RANTES Deposition by Platelets Triggers Monocyte Arrest on Inflamed and Atherosclerotic Endothelium

Philipp von Hundelshausen, Kim S. C. Weber, Yuqing Huo et al. · Circulation · 2001 · 578 citations

, , +17

1–5 of 175